Literature DB >> 16176729

Screening for depression in primary care.

David Kessler, Deborah Sharp, Glyn Lewis.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16176729      PMCID： PMC1464083     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  9 in total

1.  Screening for depression: recommendations and rationale.

Authors: 
Journal:  Ann Intern Med       Date:  2002-05-21       Impact factor: 25.391

2.  Detection of depression and anxiety in primary care: follow up study.

Authors:  David Kessler; Olive Bennewith; Glyn Lewis; Deborah Sharp
Journal:  BMJ       Date:  2002-11-02

3.  Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial.

Authors:  K B Wells; C Sherbourne; M Schoenbaum; N Duan; L Meredith; J Unützer; J Miranda; M F Carney; L V Rubenstein
Journal:  JAMA       Date:  2000-01-12       Impact factor: 56.272

4.  Opportunity cost of antidepressant prescribing in England: analysis of routine data.

Authors:  Sandra Hollinghurst; David Kessler; Tim J Peters; David Gunnell
Journal:  BMJ       Date:  2005-03-18

5.  Lay people's attitudes to treatment of depression: results of opinion poll for Defeat Depression Campaign just before its launch.

Authors:  R G Priest; C Vize; A Roberts; M Roberts; A Tylee
Journal:  BMJ       Date:  1996-10-05

6.  The effectiveness of case-finding for mental health problems in primary care.

Authors: 
Journal:  Br J Gen Pract       Date:  2005-09       Impact factor: 5.386

7.  GP treatment decisions for patients with depression: an observational study.

Authors:  Tony Kendrick; Fiona King; Louise Albertella; Peter Wf Smith
Journal:  Br J Gen Pract       Date:  2005-04       Impact factor: 5.386

Review 8.  Routinely administered questionnaires for depression and anxiety: systematic review.

Authors:  S M Gilbody; A O House; T A Sheldon
Journal:  BMJ       Date:  2001-02-17

Review 9.  Interventions used in disease management programmes for patients with chronic illness-which ones work? Meta-analysis of published reports.

Authors:  Scott R Weingarten; James M Henning; Enkhe Badamgarav; Kevin Knight; Vic Hasselblad; Anacleto Gano; Joshua J Ofman
Journal:  BMJ       Date:  2002-10-26
  9 in total
  12 in total

1.  Anxiety, depression, and inflammation after restorative proctocolectomy.

Authors:  Venkata Subhash Gorrepati; Sanjay Yadav; August Stuart; Walter Koltun; Evangelos Messaris; Emmanuelle D Williams; Matthew D Coates
Journal:  Int J Colorectal Dis       Date:  2018-06-29       Impact factor: 2.571

2.  Exploring potential explanations for the increase in antidepressant prescribing in Scotland using secondary analyses of routine data.

Authors:  Rosalia Munoz-Arroyo; Matt Sutton; Jill Morrison
Journal:  Br J Gen Pract       Date:  2006-06       Impact factor: 5.386

3.  Creatine, similarly to ketamine, affords antidepressant-like effects in the tail suspension test via adenosine A₁ and A2A receptor activation.

Authors:  Mauricio P Cunha; Francis L Pazini; Julia M Rosa; Ana B Ramos-Hryb; Ágatha Oliveira; Manuella P Kaster; Ana Lúcia S Rodrigues
Journal:  Purinergic Signal       Date:  2015-02-22       Impact factor: 3.765

Review 4.  Stress risk factors and stress-related pathology: neuroplasticity, epigenetics and endophenotypes.

Authors:  Jason J Radley; Mohamed Kabbaj; Lauren Jacobson; Willem Heydendael; Rachel Yehuda; James P Herman
Journal:  Stress       Date:  2011-09       Impact factor: 3.493

5.  Depression Symptoms, Acculturation, Needing Care, and Receiving Care: A Study of Adolescents Living in California.

Authors:  Shahrzad Bazargan-Hejazi; Mohsen Bazargan; Magda Shaheen; Senait Teklehaimanot; Alireza Ahmadi; Joan Smith Cooper; Stacey Teruya
Journal:  J Health Dispar Res Pract       Date:  2016

6.  Defective Inflammatory Pathways in Never-Treated Depressed Patients Are Associated with Poor Treatment Response.

Authors:  Shariful A Syed; Eléonore Beurel; David A Loewenstein; Jeffrey A Lowell; W Edward Craighead; Boadie W Dunlop; Helen S Mayberg; Firdaus Dhabhar; W Dalton Dietrich; Robert W Keane; Juan Pablo de Rivero Vaccari; Charles B Nemeroff
Journal:  Neuron       Date:  2018-08-23       Impact factor: 17.173

7.  Essential roles of AMPA receptor GluA1 phosphorylation and presynaptic HCN channels in fast-acting antidepressant responses of ketamine.

Authors:  Ke Zhang; Ting Xu; Zhongmin Yuan; Zhisheng Wei; Vitor Nagai Yamaki; Mingfa Huang; Richard L Huganir; Xiang Cai
Journal:  Sci Signal       Date:  2016-12-13       Impact factor: 8.192

Review 8.  Commonalities and differences in correlates of depressive symptoms in men and women with heart failure.

Authors:  Jo-Ann Eastwood; Debra K Moser; Barbara J Riegel; Nancy M Albert; Susan Pressler; Misook L Chung; Sandra Dunbar; Jia-Rong Wu; Terry A Lennie
Journal:  Eur J Cardiovasc Nurs       Date:  2012-03-13       Impact factor: 3.908

Review 9.  Gene-environment interaction in major depression: focus on experience-dependent biological systems.

Authors:  Nicola Lopizzo; Luisella Bocchio Chiavetto; Nadia Cattane; Giona Plazzotta; Frank I Tarazi; Carmine M Pariante; Marco A Riva; Annamaria Cattaneo
Journal:  Front Psychiatry       Date:  2015-05-08       Impact factor: 4.157

10.  Management of Co-Morbidity of Depression and Chronic Non-Communicable Diseases in Rwanda.

Authors:  Madeleine Mukeshimana; Gugu Mchunu
Journal:  Ethiop J Health Sci       Date:  2017-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.